Page last updated: 2024-12-07

s 135

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S 135: GABA receptor agonist; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID113637
CHEMBL ID3144843
MeSH IDM0164457

Synonyms (8)

Synonym
s 135
2-(5-methylthien-3-yl)-2,5-dihydro-3h-pyrazolo(4,3-c)quinolin-3-one
3h-pyrazolo(4,3-c)quinolin-3-one, 2,5-dihydro-2-(5-methyl-3-thienyl)-
104679-67-6
CHEMBL3144843
2-(5-methylthiophen-3-yl)-2,5-dihydro-3h-pyrazolo[4,3-c]quinolin-3-one
2-(5-methylthiophen-3-yl)-1,2-dihydro-3h-pyrazolo[4,3-c]quinolin-3-one
DTXSID20909122
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID40967Binding affinity against benzodiazepine (BZ) receptor by displacing [3H]diazepam in cerebral cortex of Wistar rats1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors.
AID348954Displacement of [3H]diazepam from GABAA/BzR in rat brain membrane2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
AID110217Ability to inhibit pentylenetetrazole (PTZ) induced convulsions in mice after peroral administration at 75 mg/Kg; Range is between (0.47-0.94)1987Journal of medicinal chemistry, Mar, Volume: 30, Issue:3
A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors.
AID39938Displacement of [3H]diazepam from rat cerebral cortex benzodiazepine receptor1996Journal of medicinal chemistry, Jul-05, Volume: 39, Issue:14
Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands.
AID131056Inverse agonist activity of orally administered compound against a subcutaneous dose of 75 mg/kg of PTZ-induced convulsions in mice1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors.
AID110218Ability to inhibit pentylenetetrazole (PTZ) induced convulsions in mice after peroral administration at 90 mg/Kg1987Journal of medicinal chemistry, Mar, Volume: 30, Issue:3
A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors.
AID131059Inverse agonist activity of orally administered compound against a subcutaneous dose of 90 mg/kg of PTZ-induced convulsions in mice1988Journal of medicinal chemistry, Sep, Volume: 31, Issue:9
Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors.
AID40966Displacement of [3H]-diazepam from GABA-A benzodiazepine receptor of rat cerebral cortex1987Journal of medicinal chemistry, Mar, Volume: 30, Issue:3
A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors.
AID493017Wombat Data for BeliefDocking2002European journal of medicinal chemistry, Mar, Volume: 37, Issue:3
Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.29 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index80.94 (26.88)
Search Engine Supply Index2.17 (0.95)

This Compound (50.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]